Pacira Sues FDA Over Constraints On Pain Drug's Marketing
By Daniel Langhorne ( September 8, 2015, 10:51 PM EDT) -- Pacira Pharmaceuticals Inc. on Tuesday filed a lawsuit against the U.S. Food and Drug Administration claiming the agency's unilateral attempt to quash the company's off-label marketing for pain medication Exparel violated the Administrative Procedure Act....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.